Next-generation organ-on-chip technology for human-accurate safety & efficacy prediction.
CompreVie is at the forefront of biotechnology research, pioneering next-generation organ-on-chip technology to deliver human-accurate safety and efficacy predictions. CompreVie's innovative platform enables comprehensive preclinical testing using 100% human models, effectively eliminating the need for animal testing. This approach significantly improves drug success rates and enhances the safety of everyday products.
CompreVie is dedicated to driving sustainability within the pharmaceutical and cosmetics industries through advanced bio-healthtech solutions. Located in Vienna, AT, CompreVie specializes in a range of cutting-edge techniques, including in vitro diagnostics, skin models, and microphysiological systems. The company's expertise extends to areas such as wounding, microfluidics, alternative pre-clinical methods, and the development of long-term and personalized in vitro models.
CompreVie is committed to providing superior pre-clinical solutions, contributing to safer and more effective product development. We invite the management team at CompreVie to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.
Other organizations in the same industry
This company is also known as